GlySens

company

About

GlySens Incorporated is a privately held corporation that is committed to developing a long term glucose sensor system to continuously

  • 51 - 100

Details

Last Funding Type
Grant
Last Funding Money Raised
$2M
Industries
Health Care,Manufacturing,Medical Device
Founded date
Jan 1, 1998
Number Of Employee
51 - 100
Operating Status
Active

GlySens Incorporated is a privately held corporation devoted to developing the world’s first truly long term continuous glucose monitoring system, intended to dramatically improve the lives of people with diabetes. The GlySens fully implanted sensor—demonstrated up to 18 month lifetime in preclinical testing—wirelessly links to a convenient external receiver, designed to provide continuous, at-a-glance glucose measurement, recording, and alerts regarding hypo- and hyperglycemic glucose excursions. In contrast with other approaches that may require calibration multiple-times-per-day, system calibration checks of the GlySens sensor are designed to be required only infrequently, freeing users from the need for burdensome care and maintenance.

For people living with diabetes, the GlySens implantable continuous glucose monitoring system (the GlySens ICGMTM system) is intended to provide a means for easy, unobtrusive, worry-free glucose monitoring, and empower users by providing the information they need, while freeing them to live life on their own terms. The GlySens ICGM system is currently undergoing clinical evaluation; initial human implant trials have been completed, and preparations for additional human trials are underway.

Funding Rounds

Number of Funding Rounds
Total Funding Amount
1
$2M
GlySens has raised a total of $2M in funding over 2 rounds. Their latest funding was raised on Nov 24, 2014 from a Grant round.
Announced Date Round Money Raised Number of Investors Lead Investors Post Valuation
Nov 24, 2014 Grant $2M 1 Detail

Investors

Number of Lead Investors
Number of Investors
1
GlySens is funded by 1 investors. National Institutes of Health are the most recent investors.
Investor Name Lead Investor Funding Round
National Institutes of Health Grant